CSR

Building on Our Declaration of Conduct to Deepen Our CSR Initiatives.

CSR

Building on Our Declaration of Conduct to Deepen Our CSR Initiatives.

External Evaluation

  • Dow Jones Sustainability Indices (DJSI)

    Dow Jones Sustainability Indices (DJSI)

    The DJSI are SRI indices developed through collaboration between S&P Dow Jones Indices(U.S.) and RobecoSAM(Switzerland). Sustainability of corporate activity is evaluated on the basis of three dimensions --economic, environmental, and social-- with recognition given to outstanding companies. Sumitomo Dainippon Pharma was selected to the Dow Jones Sustainability Asia/Pacific Index (DJSI Asia/Pacific), the Asia Pacific subset of the 2017 Dow Jones Sustainability Indices (DJSI) as of September 2017.
  • FTSE4Good Index Series

    FTSE4Good

    The FTSE4Good Index Series is created by the global index provider FTSE Russell (U.K.) to measure the performance of companies demonstrating strong Environmental, Social and Governance (ESG) practices. Sumitomo Dainippon Pharma has been independently assessed according to the FTSE4Good criteria, and has continuously satisfied the requirements to become a constituent of this index series since 2003.
  • FTSE Blossom Japan Index

    FTSE Blossom Japan Index

    The FTSE Blossom Japan Index is created by the global index provider FTSE Russell (U.K.) to measure the performance of Japanese companies demonstrating strong Environmental, Social and Governance (ESG) practices. Sumitomo Dainippon Pharma has been independently assessed according to the FTSE Blossom Japan Index criteria, and has satisfied the requirements to become a constituent of this index as of June 2017.
  • MSCI Global Sustainability Indexes

    MSCI Global Sustainability Indexes

    The MSCI Global Sustainability Indexes is a globally renowned SRI (Socially Responsible Investment) index generated MSCI Inc. of the U.S. Sumitomo Dainippon Pharma has been independently assessed according to the MSCI Global Sustainability Indexes criteria, and has continuously satisfied the requirements to become a constituent of these indexes since 2010.
  • MSCI Japan ESG Select Leaders Index

    MSCI

    The MSCI Japan ESG Select Leaders Index targets 50% of the free float-adjusted market capitalization of each Global Industry Classification Standard (GICS®) Sector and is designed to target companies that have high Environmental, Social and Governance (ESG) performance. Sumitomo Dainippon Pharma has been independently assessed according to the MSCI Japan ESG Select Leaders Index criteria, and has satisfied the requirements to become a constituent of this index as of June 2017.
  • MSCI Japan Empowering Women Index (WIN)

    WIN

    The MSCI Japan Empowering Women Index (WIN) aims to represent the performance of companies that are leading within their GICS® sector groups in terms of promoting and maintaining gender diversity while also meeting certain quality factor criteria. Sumitomo Dainippon Pharma has been independently assessed according to the MSCI Japan Empowering Women Index (WIN) criteria, and has satisfied the requirements to become a constituent of this index as of June 2017.
  • MS-SRI

    MS-SRI

    MS-SRI is a socially responsible investment stock index of 150 companies selected from about 4,000 listed Japanese companies by Morningstar based on their social quality. Sumitomo Dainippon Pharma was selected to the index as of January 2017.
  • SNAM Sustainability Index

    SNAM Sustainability Index

    The SNAM Sustainability index is created by the SOMPO JAPAN Nippon Asset Management (SOMPO JAPAN), and is used in SRI (socially responsible investment) fund for pension funds or institutional investors to invest widely in companies with the high ESG (environment, society, governance) evaluation ratings. Sumitomo Dainippon Pharma was selected to this index as of June 2017.